# Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery

> **NCT04472299** · PHASE4 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 32 (actual)

## Conditions studied

- New Onset Atrial Fibrillation
- Anesthesia, Local
- Cardiac Disease

## Interventions

- **DRUG:** Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT04472299
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-09
- **Primary completion:** 2025-07-08
- **Final completion:** 2025-07-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04472299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04472299, "Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04472299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*